Further observations on the activation and inhibition of lipoprotein lipase by apolipoproteins.
D000273:Adipose Tissue / Q000201:enzymology / Q000378:metabolism; D000818:Animals; D001059:Apoproteins / Q000008:administration & dosage / Q000302:isolation & purification / Q000494:pharmacology*; D011232:Chemical Precipitation; D011756:Diphosphates; D004591:Electrophoresis, Polyacrylamide Gel; D004789:Enzyme Activation / Q000187:drug effects; D006801:Humans; D007106:Immune Sera; D005779:Immunodiffusion; D007700:Kinetics; D008071:Lipoprotein Lipase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D008074:Lipoproteins / Q000302:isolation & purification / Q000494:pharmacology*; D008075:Lipoproteins, HDL / Q000378:metabolism; D008079:Lipoproteins, VLDL / Q000378:metabolism; D011479:Protamines; D011817:Rabbits; D051381:Rats; D012964:Sodium; D012965:Sodium Chloride; D013997:Time Factors; D014304:Triolein
D001059:Apoproteins; D011756:Diphosphates; D007106:Immune Sera; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D008079:Lipoproteins, VLDL; D011479:Protamines; D014304:Triolein; D012965:Sodium Chloride; D012964:Sodium; D008071:Lipoprotein Lipase